Skip to Content
  • Retraction
  • Open Access

30 June 2026

2 Pages

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993

,
,
,
,
,
,
,
,
…
1
Pathology Unit, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
2
Department of Precision Medicine “F. Magrassi e A. Lanzara”, Institute of Medical Oncology, 80138 Naples, Italy
3
Pathology Unit, ASL AL, 15033 Casale Monferrato, Italy
4
Translational Medical and Surgical Science, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
The journal retracts the article titled “AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of figures published in this article [1].
In accordance with standard journal procedures, the Editorial Office and Editorial Board conducted an investigation that identified image duplication with figures previously published in an article [2], authored by a similar research group and presenting different experimental conditions. Although the authors cooperated with the investigation, the explanations and supporting materials provided were insufficient, in the Editorial Board’s assessment, to resolve the identified concerns or establish the provenance of the images. Consequently, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1], as per MDPI’s retraction policy.
This retraction was approved by the Editor-in-Chief of the journal JPM.
The authors have been informed of this retraction but did not provide a comment on this decision.

References

  1. Zito Marino, F.; Della Corte, C.M.; Ciaramella, V.; Erra, S.; Ronchi, A.; Fiorelli, A.; Vicidomini, G.; Santini, M.; Scognamiglio, G.; Morgillo, F.; et al. RETRACTED: AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Martinelli, E.; Martini, G.; Cardone, C.; Troiani, T.; Liguori, G.; Vitagliano, D.; Napolitano, S.; Morgillo, F.; Rinaldi, B.; Melillo, R.M.; et al. AXL is an oncotarget in human colorectal cancer. Oncotarget 2015, 6, 23281–23296. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.